InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by BRYANT DOUGLAS C, Chairman & CEO. Director active across 2 companies, notably QUIDEL CORP. In total, 12 reports have been logged. The latest transaction was disclosed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations12 total
505,926 shares
Common Stock
SEC:0000899243-22-020387:0·
505,926 shares
Common Stock
SEC:0000899243-22-020508:0·
03,795 shares0
Common Stock
SEC:0001209191-22-007617:0·
03,795 shares0
Common Stock
SEC:0001209191-22-007617·
03,795 shares0
Common Stock
SEC:0001209191-22-007618·
03,795 shares0
Common Stock
SEC:0001209191-22-007618:0·
01,115 shares0
Common Stock
SEC:0001209191-22-006631:0·
01,115 shares0
Common Stock
SEC:0001209191-22-006631·
013,819 shares0
Common Stock
SEC:0001209191-22-003870·
013,819 shares0
Common Stock
SEC:0001209191-22-003870:0·
01,460 shares0
Common Stock
SEC:0001209191-21-053551·
01,460 shares0
Common Stock
SEC:0001209191-21-053551:0·
12 of 12 declarations
About BRYANT DOUGLAS C
Douglas C. Bryant is the Chairman and CEO of QUIDEL CORP /DE/ and QuidelOrtho Corp. He is responsible for the strategic direction and management of operations for both companies. With extensive experience in the healthcare sector, he plays a key role in optimizing services and customer engagement. His leadership focuses on sustainable growth and innovation in the diagnostics industry.
